Merck cites EnWave\-\-s REV? Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics
Home » Internet » Merck cites EnWave\-\-s REV? Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics Merck cites EnWave\-\-s REV? Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics Posted by PublisherInternet Tuesday, 26. January 2021 EnWave Corporation (TSX-V:ENW | FSE:E4U) (?EnWave?, or the ?Company? https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/)?announces today that Merck & Co. Inc (?Merck?) published a research paper citing ?EnWave?s freezeREV? process as a v...
Source: so-co-it.com